3.1.6. Social and Economic Disease Burden ffects patients' quality of life. Studies have shown that the impact of hyperhidrosis on quality of life equals or exceeds that of other …

Hyperhidrosis Patient Survey Botanix Pharmaceuticals (ASX:BOT) are preparing to launch their product, Sofdra

Sep 26, 2022 · Botanix has today announced the submission of a New Drug Application to the FDA for approval of Sofpironium Bromide for the treatment of severe primary axillary …

Audience Quality/ROI Audience/ Creative Media and Website Engagement Metrics Single Channel KPIs

Botanix’s lead product is Sofdra ™ (sofpironium bromide) gel, 15%, a drug in development for the treatment of primary axillary hyperhidrosis, where excessive sweating occurs beyond what is …

E&P Comments BOT management have announced a Commercial Day Webinar (17-Sept-2024) during which they will provide a comprehensive update on the commercialisation and launch …

Apr 6, 2017 · Botanix is focussed on skin disease and acne treatments using a synthetic cannabidoil. The regulators usually prefer synthetic variants of botanic products because their …

Demand for better treatments are evident by the impact of hyperhidrosis on quality of life, with a 2016 study (Hamm H. et al. Dermatology) stating: “... Over half (54%) of respondents say that …

Dec 5, 2018 · Novel multi-drug comparison study format in the same patient, provides high quality data on BTX 1308 efficacy Biopsy data will elucidate MOA and (for the first time) confirm anti …

Cyclical Risk Qualitative assessment of the 2-year outlook for a stock/industry’s profit cycle. Industry Quality Qualitative assessment of an industry’s growth/returns potential and company …